Completed PHASE4 INTERVENTIONAL 4-arm NCT00487773

Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With Asthma

Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With Asthma - Randomized, Controlled Trial.

Sponsor: Medical University of Lodz

Conditions Asthma

Interventions D3 vitamin budesonide montelukast sodium salbutamol

Updated 6 times since 2017 Last updated: Apr 12, 2010 Started: Sep 30, 2007 Primary completion: Sep 30, 2008 Completion: Sep 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Asthma and is currently completed. Medical University of Lodz leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Oct 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Oct 2021 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Lodz

Data source: Medical University of Lodz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lodz, Poland